Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 double-blind randomized crossover mannitol challenge study of CRD007 in adults with asthma
2015-000120-28Phase 2Completed
- Sponsor
- RSPR Pharma
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pemirolast in asthma, sponsored by RSPR Pharma. Primary endpoint: PD15 for mannitol after treatment with CRD007 and placebo. Started Feb 2015; status: completed.
02
Drugs
pemirolast
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-000120-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000120-28.